sinopharm

Bankers to cash in on China's SOE reforms

Reform of China’s sprawling state-owned enterprises is generating lucrative assignments for bankers. However they must be in it for the long-haul as change will take time.

July 16, 2014

China's SOE reform gathers pace

Sinopharm and China National Building Materials are next in line for further privatization as Beijing revamps its debt-laden state sector.

July 15, 2014

Fosun Pharmaceutical seeks $594 million from HK listing

Prudential agrees to buy $50 million worth of shares, bringing the total cornerstone investment to $75 million.

October 17, 2012

China Medical System aims to raise $129 million from Hong Kong IPO

The pharmaceutical services company fights for investor attention along with 10 other Chinese companies that plan to launch small to mid-size share sales in Hong Kong or the US this month.

September 09, 2010

Sinopharm sets price range for $1.13 billion IPO

The Chinese distributor of pharmaceutical products will be the first company to take orders for a Hong Kong listing after the summer and has set the price range at HK12.25 to HK$16 per share.

September 03, 2009